ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
減肥藥
1,229.37
+8.24
0.67%
漲家數:
6
跌家數:
1
平家數:
- -
市盈率:
- -
高:
1,240.78
開:
1,222.44
低:
1,222.44
收:
1,221.13
資料載入中...
總覽
新聞
斯洛伐克總理暫停購買 COVID-19 疫苗,等待審查
路透中文
·
04-23
碩迪生物盤中異動 股價大漲5.03%報24.20美元
市场透视
·
04-23
Viking Therapeutics, Inc.盤中異動 早盤急速拉昇5.02%報26.76美元
市场透视
·
04-23
諾和諾德盤中異動 股價大漲3.66%
市场透视
·
04-23
Altimmune, Inc.盤中異動 急速拉昇5.57%
市场透视
·
04-23
諾和諾德4月22日成交額為6.98億美元
市场透视
·
04-23
安進4月22日成交額為5.77億美元
市场透视
·
04-23
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1229.3689,"timestamp":1746647999999,"preClose":1221.1315,"halted":0,"volume":74672216,"delay":0,"changeRate":0.006746,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":8.237427,"latestTime":"05-07 16:00:00 EDT","open":1222.4443,"high":1240.7821,"low":1222.438,"amount":5800122828.734317,"amplitude":0.015022,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.914023,"peRate":33.22472,"turnoverRate":0.00706,"increases":6,"decrements":1,"flats":0,"marketCap":1318906989056,"floatMarketCap":1231878410112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1240.7821,"amplitude":0.015022,"preClose":1221.1315,"low":1222.438,"pbRate":"9.914023","latestPrice":1229.3689,"volume":74672216,"delay":0,"open":1222.4443,"prevYearClose":1305.0607,"prevWeekClose":1289.8245,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1353.2255,"twentyDayClose":1158.9794,"sixtyDayClose":1402.1769,"secType":"PLATE","market":"US","turnoverRate":0.00706,"peRate":33.22472,"marketCap":1318906989056,"floatMarketCap":1231878410112,"timestamp":1746647999999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529631052","title":"斯洛伐克總理暫停購買 COVID-19 疫苗,等待審查","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631052","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631052?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 23:34","pubTimestamp":1745422499,"startTime":"0","endTime":"0","summary":"斯洛伐克总理暂停购买 COVID-19 疫苗,等待审查路透4月23日 - 斯洛伐克总理罗伯特-菲佐表示,斯洛伐克政府已于周三停止采购 COVID-19 疫苗,等待斯洛伐克科学院对其安全性进行审查。科特拉尔在没有证据的情况下声称基于 mRNA 技术的疫苗不安全,并呼吁政府停止接种。菲佐曾多次怀疑接种COVID-19疫苗的好处,并在大流行期间组织了一次违反封锁规定的抗议活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4S3R11OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4599","LU0122379950.USD","IE00BBT3K403.USD","LU0306807586.USD","BK4585","LU0234572021.USD","BK4592","LU0321505868.SGD","LU0985481810.HKD","MRNA","BK4548","LU0170899867.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","BK4588","BK4532","LU0868494617.USD","SG9999001176.SGD","IE000M9KFDE8.USD","BK4581","IE00B19Z3581.USD","LU0225771236.USD","BK4533","LU0058720904.USD","BK4568","BK4501","IE0002270589.USD","LU1057294990.SGD","BK4550","LU1894683264.USD","BK4534","BK4551","SG9999002224.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU1066053197.SGD","LU0321505439.SGD","LU0289739699.SGD","LU1894683348.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK4007","LU0306806265.USD","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2529268009","title":"碩迪生物盤中異動 股價大漲5.03%報24.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529268009?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 22:10","pubTimestamp":1745417434,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时10分,硕迪生物股票出现波动,股价大幅上涨5.03%。截至发稿,该股报24.20美元/股,成交量15.5897万股,换手率0.27%,振幅4.26%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.23亿美元,每股收益-2.33美元,毛利-2.60百万美元,市盈率-10.31倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2529638207","title":"Viking Therapeutics, Inc.盤中異動 早盤急速拉昇5.02%報26.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529638207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529638207?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:52","pubTimestamp":1745416324,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时52分,Viking Therapeutics, Inc.股票出现波动,股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Instil Bio, Inc.涨幅较大,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.较为活跃,换手率分别为4635.83%、102.55%、28.99%,振幅较大的相关个股有Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Silexion Therapeutics Corp、Ensysce Biosciences, Inc.,振幅分别为101.45%、59.90%、52.94%。Viking Therapeutics, Inc.公司简介:Viking Therapeutics Inc 是一家医疗保健服务提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4007","VKTX","BK4599","LENZ","BK4588"],"gpt_icon":0},{"id":"2529631611","title":"諾和諾德盤中異動 股價大漲3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631611?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:33","pubTimestamp":1745415201,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时33分,诺和诺德股票出现异动,股价快速拉升3.66%。诺和诺德股票所在的制药行业中,整体涨幅为0.83%。诺和诺德还有一个生物制药部门,专门从事血友病和其他疾病的蛋白质疗法。消息层面,截至21时33分,《减肥药双雄死磕口服新战场减肥药双雄死磕口服新战场》资讯为影响诺和诺德的重要信息。结果公布后,诺和诺德计划在2023年提交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD","NVO","BK4532","BK4585","BK4007"],"gpt_icon":1},{"id":"2529922689","title":"Altimmune, Inc.盤中異動 急速拉昇5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529922689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529922689?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:31","pubTimestamp":1745415072,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Altimmune, Inc.股票出现波动,股价大幅拉升5.57%。截至发稿,该股报5.12美元/股,成交量5.5037万股,换手率0.07%,振幅0.41%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Altimmune, Inc.公司简介:Altimmune Inc 是一家处于临床阶段的生物制药公司,专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"2529251860","title":"諾和諾德4月22日成交額為6.98億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529251860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529251860?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 10:11","pubTimestamp":1745374270,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日,诺和诺德成交额为6.98亿美元,成交额较昨日减少10.34%,当日成交量为1169.79万股。诺和诺德于2025年4月22日涨2.71%,报59.91美元,该股过去5个交易日跌9.31%,年初至今跌29.52%,过去60日跌31.08%。诺和诺德还有一个生物制药部门,专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4007","BK4599","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532","BK4588"],"gpt_icon":1},{"id":"2529591552","title":"安進4月22日成交額為5.77億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529591552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:15","pubTimestamp":1745370948,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日,安进成交额为5.77亿美元,成交额较昨日增加16.93%,当日成交量为208.10万股。安进于2025年4月22日涨1.72%,报278.4美元,该股过去5个交易日跌5.28%,年初至今涨7.68%,过去60日涨1.9%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU1023059063.AUD","LU0289739699.SGD","LU1057294990.SGD","BK4533","LU1061106388.HKD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4581","BK4599","LU0320765992.SGD","LU2089984988.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","BK4534","LU0109394709.USD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4588","LU1571399168.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2242652126.USD","LU1983299246.USD","SG9999001440.SGD","BK4585","LU2242646821.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":127,"code":"91000000","status":"200"}]}}